ブライトパス.バイオ株式会社 · BRIGHTPATH BIOTHERAPEUTICS CO., LTD.

BrightPath Biotherapeutics Co., Ltd. is a Japan-based company mainly engaged in the development of pharmaceutical products. The Company is a biopharmaceutical venture company focused on developing cancer immunotherapeutic. The Companies business model covers drug discovery research and early clinical development of cancer immunotherapy; conducting of early-phase clinical trials; and development, manufacturing, and launching of the drugs as commercial products in Japan and abroad. The Company also generates the revenues from license fees from the pharmaceutical companies. Employees 42 Sector Biotechnology & Medical Research Calendar Earnings release - Q1 2027